Latest Options And Warrants News

Global Uranium and Enrichment Limited has obtained a crucial ASX waiver allowing the cancellation of certain unlisted options without shareholder approval, smoothing the path for Snow Lake Resources’ acquisition scheme.

Tombador Iron Limited has completed its strategic acquisition of GoviEx Uranium Inc., paving the way for a relisting as Atomic Eagle Ltd focused on uranium exploration.

Novo Resources Corp. reported a reduced net loss of CAD 9.7 million for the nine months to September 2025, supported by lower operating cash outflows and a significant post-period sale of San Cristobel Mining shares. The company maintains a cautious outlook amid ongoing funding needs.

Mesoblast has entered agreements to issue up to US$50 million in convertible notes, aiming to strengthen its capital base and support pipeline growth, pending shareholder approval.

Imricor Medical Systems reported a sharp 52% revenue decline and a 92% increase in net loss for H1 2025, offset by a $42.8 million equity raise boosting liquidity. The company is investing heavily in European sales and clinical trials while pursuing FDA approval.

Almonty Industries has announced a 1-for-1.5 share consolidation approved by shareholders to streamline its capital structure in preparation for a potential Nasdaq listing.

Chimeric Therapeutics has raised $6.6 million through a discounted two-tranche placement to accelerate its promising CAR-T and NK cell therapy clinical programs. The capital raise, strongly backed by institutional and professional investors, signals growing confidence in the company’s oncology pipeline.